STEELE GLENN JR MD PHD sold 34.8% of their position (12K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $781.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/2/2026ACC: 0001269131-26-000005
Director
Since Jan 2019
-12K
Net shares
Net seller
$781.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12K acquired · 24K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12K
Price / share
$11.23
Trade value
$134.76K
% of position
53.3%
9/30/2026
22.50K→34.50K
Common Stock
Direct
Shares
−12K
Price / share
$65.16
Trade value
$781.92K
% of position
34.8%
9/30/2026
34.50K→22.50K
Total
Net shares
+0.00
Net value
-$647.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2026 | M · Option Exercise | +12K | $11.23 | $134.76K | 53.3% | 22.50K | 34.50K |
| Common Stock Direct | 9/30/2026 | S · Sale | −12K | $65.16 | $781.92K | 34.8% | 34.50K | 22.50K |
| Total | +0.00 | -$647.16K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12K shares
Shares
−12K
Strike price
11.23
Held after
0.00
Exercisable
—
9/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12K shares | 9/30/2026 | M · Option Exercise | −12K | 11.23 | — | 0.00 |